| 4MNS: reference: Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients., Nony E, Bouley J, Le Mignon M, Lemoine P, Jain K, Horiot S, Mascarell L, Pallardy M, Vincentelli R, Leone P, Roussel A, Batard T, Abiteboul K, Robin B, de Beaumont O, Arvidsson M, Rak S, Moingeon P, Allergy. 2015 Apr 2. doi: 10.1111/all.12622. PMID: 25846209 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).